Get the Stockscreener App
238.57
3.68%
-9.205
Overview
News
Price History
Option Chain
Financials
Why WST Down?
Discussions
Forecast
Stock Split
Dividend History
West Pharmaceutical Services Inc stock is traded at $238.57, with a volume of 837.88K.
It is down -3.68% in the last 24 hours and down -13.99% over the past month.
West Pharmaceutical Services is based in Pennsylvania and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), nonglass containment solutions, and auto-injectors for injectable drugs, which include large-molecule biologics, peptides such as GLP-1 receptor agonists, and small-molecule drugs. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue). It generates approximately 55% of its revenue from international markets and 45% from the United States.
See More
Previous Close:
$247.78
Open:
$246
24h Volume:
837.88K
Relative Volume:
1.11
Market Cap:
$17.16B
Revenue:
$2.96B
Net Income/Loss:
$487.70M
P/E Ratio:
35.74
EPS:
6.6758
Net Cash Flow:
$344.00M
1W Performance:
-8.13%
1M Performance:
-13.99%
6M Performance:
+4.99%
1Y Performance:
-30.62%
1-Day Range:
$232.06
$246.13
1-Week Range:
$232.06
$258.74
52-Week Range:
$187.43
$348.90
West Pharmaceutical Services Inc Stock (WST) Company Profile
Name
West Pharmaceutical Services Inc
Sector
Industry
Phone
(610) 594-2900
Address
530 HERMAN O. WEST DRIVE, EXTON, PA
Compare WST with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
WST
West Pharmaceutical Services Inc
|
238.59 | 17.83B | 2.96B | 487.70M | 344.00M | 6.6758 |
|
ISRG
Intuitive Surgical Inc
|
524.25 | 186.40B | 9.61B | 2.77B | 2.27B | 7.555 |
|
BDX
Becton Dickinson Co
|
200.47 | 58.70B | 21.84B | 1.68B | 2.67B | 5.8293 |
|
ALC
Alcon Inc
|
80.04 | 39.80B | 10.19B | 1.05B | 1.38B | 2.1044 |
|
MDLN
Medline Inc
|
45.42 | 38.25B | 27.43B | 1.27B | 1.01B | 1.5829 |
|
RMD
Resmed Inc
|
250.59 | 37.27B | 5.26B | 1.44B | 1.76B | 9.7713 |
West Pharmaceutical Services Inc Stock (WST) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-02-25 | Initiated | Morgan Stanley | Equal-Weight |
| Sep-15-25 | Initiated | Rothschild & Co Redburn | Buy |
| Jun-24-25 | Initiated | Barclays | Equal Weight |
| Mar-18-25 | Initiated | Evercore ISI | Outperform |
| Feb-14-25 | Upgrade | Deutsche Bank | Hold → Buy |
| Jan-08-25 | Initiated | Citigroup | Buy |
| Dec-13-24 | Initiated | Wolfe Research | Peer Perform |
| Dec-12-24 | Upgrade | UBS | Neutral → Buy |
| Feb-07-24 | Upgrade | Jefferies | Hold → Buy |
| Jun-16-23 | Upgrade | BofA Securities | Neutral → Buy |
| Apr-11-23 | Upgrade | Stephens | Equal-Weight → Overweight |
| Dec-14-22 | Initiated | Deutsche Bank | Hold |
| Nov-30-22 | Initiated | UBS | Neutral |
| Oct-28-22 | Downgrade | BofA Securities | Buy → Neutral |
| Nov-10-20 | Initiated | KeyBanc Capital Markets | Overweight |
| Oct-14-20 | Initiated | Stephens | Equal-Weight |
| Jul-21-20 | Upgrade | BofA Securities | Neutral → Buy |
| Apr-24-20 | Upgrade | BofA/Merrill | Underperform → Neutral |
| Dec-12-19 | Downgrade | BofA/Merrill | Neutral → Underperform |
| Jul-26-19 | Upgrade | BofA/Merrill | Underperform → Neutral |
| May-01-19 | Downgrade | Jefferies | Buy → Hold |
| Apr-23-19 | Initiated | William Blair | Outperform |
| Apr-25-18 | Downgrade | BofA/Merrill | Neutral → Underperform |
| Jan-24-18 | Initiated | Goldman | Neutral |
| Oct-17-17 | Downgrade | BofA/Merrill | Buy → Neutral |
| Oct-03-17 | Initiated | Stephens | Equal-Weight |
| Sep-15-17 | Upgrade | Jefferies | Hold → Buy |
| Oct-28-16 | Upgrade | Wells Fargo | Market Perform → Outperform |
| Sep-21-16 | Downgrade | Wells Fargo | Outperform → Market Perform |
| Mar-22-16 | Initiated | Wells Fargo | Outperform |
| May-14-10 | Reiterated | UBS | Neutral |
| Feb-23-10 | Initiated | Jefferies & Co | Buy |
| Dec-19-08 | Initiated | UBS | Neutral |
View All
West Pharmaceutical Services Inc Stock (WST) Latest News
West Pharmaceutical Services (NYSE:WST) Stock Rating Upgraded by Zacks Research - MarketBeat
Zacks Research Issues Optimistic Estimate for WST Earnings - MarketBeat
Does West Pharmaceutical (WST) Expanding Into Biologic Syringe Systems Reshape Its Combination-Product Edge? - Yahoo Finance
Zacks Industry Outlook Highlights McKesson, Cardinal Health, West Pharmaceutical and Align Technology - The Globe and Mail
Market Outlook: Is West Pharmaceutical Services Inc stock showing strong momentumEntry Point & Precise Swing Trade Alerts - baoquankhu1.vn
Performance Recap: Whats the outlook for West Pharmaceutical Services Incs sector2025 Historical Comparison & Fast Entry High Yield Tips - baoquankhu1.vn
All You Need to Know About West Pharmaceutical (WST) Rating Upgrade to Strong Buy - Yahoo Finance
West Pharmaceutical Services Inc. Stock Outperforms Competitors On Strong Trading Day - 富途资讯
After Plunging 9.7% in 4 Weeks, Here's Why the Trend Might Reverse for West Pharmaceutical (WST) - Finviz
Vest Financial LLC Sells 48,353 Shares of West Pharmaceutical Services, Inc. $WST - MarketBeat
Rakuten Investment Management Inc. Takes $24.68 Million Position in West Pharmaceutical Services, Inc. $WST - MarketBeat
United States Vaccine Packaging Market to hit US$ 870 Million - openPR.com
West launches prefillable syringe system at Pharmapack 2026 - Investing.com
West Pharmaceutical Launches New Prefillable Syringe System to Enhance Drug Delivery - Intellectia AI
West Synchrony™ S1 Prefillable Syringe System Commercially Available at Pharmapack - PR Newswire
West Pharmaceutical Services stock: Is WST underperforming the healthcare sector? - MSN
Upslope Capital Management Exited West Pharmaceutical (WST) for Better Opportunities - Yahoo Finance
Reasons to add West Pharmaceutical stock to your portfolio now - MSN
Aug Breakouts: Is West Pharmaceutical Services Inc stock showing strong momentumJuly 2025 Outlook & Verified Chart Pattern Trade Signals - baoquankhu1.vn
West Pharmaceutical Services, Inc. (NYSE:WST) Receives Consensus Recommendation of "Moderate Buy" from Brokerages - MarketBeat
West Pharmaceutical Services (NYSE:WST) Stock Price Down 5.1%What's Next? - MarketBeat
West Pharmaceutical Services Inc (WST) Stock Price Down 4.85% on Jan 16 - GuruFocus
West Pharmaceutical Services, Inc. $WST Shares Sold by EULAV Asset Management - MarketBeat
AbbVie to buy Arizona manufacturing facility from West Pharmaceutical - MSN
Palmetto Grain Brokerage - Palmetto Grain Brokerage
Earnings Preview: What to Expect From West Pharmaceutical Services' Report - Barchart.com
Is West Pharmaceutical Services (WST) Pricing Look Stretched After Recent Share Price Weakness - Sahm
Reasons to Add West Pharmaceutical Stock to Your Portfolio Now - Finviz
Gov. Braun accelerates life sciences leadership with more than 1,300 new high wage jobs across the state - WBIW
Is It Time To Reassess West Pharmaceutical Services (WST) After Its Recent Share Price Slide - Yahoo Finance
AbbVie To Buy Device Manufacturing Facility From West Pharmaceutical Services - Med Device Online
Wall Street Analysts See a 26.42% Upside in West Pharmaceutical (WST): Can the Stock Really Move This High? - sharewise.com
AbbVie Gets Tariff Relief, Pledges $100 Billion, Lower Prices For Key Medicines - Benzinga
AbbVie adds Arizona plant to $10bn US manufacturing push - The Pharma Letter
Chicago's AbbVie to acquire Tempe medical device manufacturing facility - The Business Journals
Key facts: AbbVie partners with RemeGen; acquires West Pharma rights - TradingView — Track All Markets
Strategy To YieldBoost West Pharmaceutical Services From 0.3% To 5.2% Using Options - Nasdaq
AbbVie Inc. (NYSE : ABBV) entered into a definitive agreement to acquire Device manufacturing facility in Tempe, Arizona from West Pharmaceutical Services, Inc. (NYSE - marketscreener.com
West Pharmaceutical Selling SmartDose 3.5mL On-Body Delivery System Manufacturing Rights To AbbVie For $112.5 Million - Pulse 2.0
AbbVie Gets Tariff Relief, Pledges $100 Billion, Lower Prices For Key Medicines - Sahm
West Pharmaceutical Services To Sell SmartDose Assets To AbbVie - citybiz
AbbVie to acquire West Pharmaceutical’s Arizona facility for $175 million By Investing.com - Investing.com Canada
AbbVie to acquire West Pharmaceutical’s Arizona device manufacturing facility - Indian Pharma Post
AbbVie to Acquire Drug Delivery System, Arizona Manufacturing Facility from West Pharma - marketscreener.com
West Pharmaceutical (WST) to Sell SmartDose System Rights to Abb - GuruFocus
West Pharmaceutical (WST) Sells Arizona Facility to AbbVie for E - GuruFocus
AbbVie to buy Arizona manufacturing facility from West Pharmaceutical (WST:NYSE) - Seeking Alpha
West Signs Agreement to Sell the Manufacturing and Supply Rights for SmartDose® 3.5mL On-Body Delivery System to AbbVie - Nasdaq
Drugmaker bringing 200 jobs to Arizona plant for next-gen medicines - Stock Titan
West Pharmaceutical Services, Inc. $WST Shares Sold by Parnassus Investments LLC - MarketBeat
West Pharmaceutical Services and Philadelphia Eagles Partner for Earth Day Initiative - MSN
West Pharmaceutical Services Inc Stock (WST) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.04%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):